Bibliography
- Lanza GM , WallaceKD, ScottMJet al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 94, 3334–3340 (1996).
- Flacke S , FischerS, ScottMJet al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104, 1280–1285 (2001).
- Yu X , SongSK, ChenJet al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. 44, 867–872 (2000).
- McCarthy JR , PatelP, BotnaruI, HaghayeghiP, WeisslederR, JafferFA. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug. Chem.20, 1251–1255 (2009).
- Jaffer FA , TungCH, WykrzykowskaJJet al. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110, 170–176 (2004).
- Ripplinger CM , LiC, KimJ, McCarthyJR, LinCP, JafferFA. Multispectral in vivo molecular, functional, and anatomical imaging of venous thrombosis resolution. Arterioscleros. Throm. Vasc. Biol.30, E183–E321 (2010).
- Anderson HV , WillersonJT. Thrombolysis in acute myocardial infarction. N. Engl. J. Med.329, 703–709 (1993).
- Armstrong PW , CollenD. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Circulation103, 2862–2866 (2001).
- No authors listed. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med.333, 1581–1587 (1995).
- Bi F , ZhangJ, SuY, TangYC, LiuJN. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. Biomaterials30, 5125–5130 (2009).
- Ma YH , WuSY, WuT, ChangYJ, HuaMY, ChenJP. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials30, 3343–3351 (2009).
- Marsh JN , SenpanA, HuGet al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomedicine (Lond.) 2, 533–543 (2007).
- Marsh JN , HuG, ScottMJet al. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine (Lond.) 6, 605–615 (2011).